ES2138659T3 - Sistemas terapeuticos transdermales para la administracion de agonistas de la serotonina. - Google Patents

Sistemas terapeuticos transdermales para la administracion de agonistas de la serotonina.

Info

Publication number
ES2138659T3
ES2138659T3 ES94915109T ES94915109T ES2138659T3 ES 2138659 T3 ES2138659 T3 ES 2138659T3 ES 94915109 T ES94915109 T ES 94915109T ES 94915109 T ES94915109 T ES 94915109T ES 2138659 T3 ES2138659 T3 ES 2138659T3
Authority
ES
Spain
Prior art keywords
administration
transdermal therapeutic
therapeutic systems
serotonin agonists
active substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94915109T
Other languages
English (en)
Inventor
Harald List
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2138659T3 publication Critical patent/ES2138659T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A SISTEMAS TERAPEUTICOS TRANSDERMALES PARA LA ADMINISTRACION SISTEMATICA DE SUSTANCIA ACTIVA, QUE SE CARACTERIZA DE TAL MODO, QUE AL MENOS UNA DE LAS SUSTANCIAS ACTIVAS ES UN AGONISTA DE SEROTONINA A PARTIR DEL GRUPO DE DERIVADOS INDOL, POR EJEMPLO SUMATRIPTAN.
ES94915109T 1993-05-06 1994-04-25 Sistemas terapeuticos transdermales para la administracion de agonistas de la serotonina. Expired - Lifetime ES2138659T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4314976A DE4314976C1 (de) 1993-05-06 1993-05-06 Transdermale therapeutische Systeme zur Verabreichung von Wirkstoffen, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
ES2138659T3 true ES2138659T3 (es) 2000-01-16

Family

ID=6487316

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94915109T Expired - Lifetime ES2138659T3 (es) 1993-05-06 1994-04-25 Sistemas terapeuticos transdermales para la administracion de agonistas de la serotonina.

Country Status (20)

Country Link
EP (1) EP0697869B1 (es)
JP (1) JPH08509749A (es)
KR (1) KR960702306A (es)
AT (1) ATE183392T1 (es)
AU (1) AU686159B2 (es)
CA (1) CA2160776A1 (es)
CZ (1) CZ289395A3 (es)
DE (2) DE4314976C1 (es)
DK (1) DK0697869T3 (es)
ES (1) ES2138659T3 (es)
FI (1) FI955260A (es)
GR (1) GR3031639T3 (es)
HU (1) HUT74865A (es)
IL (1) IL109509A (es)
NO (1) NO954414D0 (es)
NZ (1) NZ265949A (es)
PL (1) PL179353B1 (es)
SK (1) SK138095A3 (es)
WO (1) WO1994026270A1 (es)
ZA (1) ZA942872B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10510540A (ja) * 1994-12-12 1998-10-13 オメロス メディカル システムズ，インコーポレーテッド 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
EP1170006B8 (en) * 1999-12-14 2008-03-19 Teikoku Seiyaku Co., Ltd. Drug for alleviating migraine
EP1435945B1 (en) * 2001-06-05 2008-08-13 Aung-din, Ronald Topical migraine therapy
US8329734B2 (en) 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
JP4616009B2 (ja) 2002-12-26 2011-01-19 ポーゼン インコーポレイテッド ＮＳＡＩＤｓおよびトリプタンを含有する多層剤型
CA2529528A1 (en) 2003-06-20 2004-12-29 Ronald Aung-Din Topical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
MX2008007897A (es) 2005-12-20 2009-03-04 Teikoku Pharma Usa Inc Metodos para administrar transdermicamente un agonista de receptor de indol serotonina y composiciones transdermicas para uso con los mismos.
NZ610790A (en) 2006-04-13 2015-05-29 Nupathe Inc Transdermal methods and systems for the delivery of anti-migraine compounds
US8592424B2 (en) 2008-06-30 2013-11-26 Afgin Pharma Llc Topical regional neuro-affective therapy
NZ599344A (en) 2009-09-25 2015-02-27 Reddy’S Lab Ltd Dr Formulations comprising triptan compounds
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
JP6216151B2 (ja) * 2013-04-19 2017-10-18 コスメディ製薬株式会社 親水性薬物のエマルジョンパッチ
BR112017018944A2 (pt) 2015-03-02 2018-05-15 Afgin Pharma Llc método de tratamento de um estado ou condição de doença em humanos com um medicamento carbinóide, e, método de tratamento de um estado ou condição de doença em um mamífero diferente de um humano com medicamento(s) carbinóide(s)
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
WO1992000103A1 (en) * 1990-06-28 1992-01-09 Beecham Group Plc Pharmaceutical preparations
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
GB9104890D0 (en) * 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions

Also Published As

Publication number Publication date
GR3031639T3 (en) 2000-02-29
KR960702306A (ko) 1996-04-27
FI955260A0 (fi) 1995-11-02
DE59408643D1 (de) 1999-09-23
IL109509A0 (en) 1994-08-26
NZ265949A (en) 1997-10-24
AU686159B2 (en) 1998-02-05
JPH08509749A (ja) 1996-10-15
WO1994026270A1 (de) 1994-11-24
PL311591A1 (en) 1996-02-19
AU6648094A (en) 1994-12-12
DE4314976C1 (de) 1994-10-06
NO954414L (no) 1995-11-03
NO954414D0 (no) 1995-11-03
PL179353B1 (en) 2000-08-31
EP0697869A1 (de) 1996-02-28
IL109509A (en) 1999-12-22
EP0697869B1 (de) 1999-08-18
DK0697869T3 (da) 2000-03-20
ZA942872B (en) 1995-07-06
CZ289395A3 (en) 1996-04-17
ATE183392T1 (de) 1999-09-15
SK138095A3 (en) 1996-06-05
FI955260A (fi) 1995-11-17
CA2160776A1 (en) 1994-11-24
HU9503167D0 (en) 1996-01-29
HUT74865A (en) 1997-02-28

Similar Documents

Publication Publication Date Title
ES2138659T3 (es) Sistemas terapeuticos transdermales para la administracion de agonistas de la serotonina.
MX9207263A (es) Sistema para el suministro de una substancia activa para la liberacion sostenida.
DE69527509T2 (de) Hydrogelformulierung mit gesteuerter freisetzung
MX9300014A (es) Nuevos derivados de 1,2,4-triaminobenceno y procedimiento para su elaboracion.
DE69735002D1 (de) Osmotisches Verabreichungssystem für lösliche Dosen
PT876815E (pt) Sistema de distribuicao de drogas para duas ou mais substancias activas
MA26456A1 (fr) Formulations pharmaceutiques pour la distribution prolongee de medicament.
BR9610875A (pt) Modulares rxr seletivos - dimeros e processos para seu uso
MX9203422A (es) Compuestos farmacologicamente activos para el sistema nervioso central.
GT199700009A (es) Terapia combinada para la osteoporosis.
PT957914E (pt) Formulacao de agonistas de 5-ht
NO943762L (no) Indolderivater som 5-HT 1 agonister
NO305906B1 (no) Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
MX9201058A (es) Derivados ciclicos de cetal, procedimiento para supreparacion y composicion farmaceutica que los contiene.
BR9608255A (pt) Sistema terapéutico transdérmico (stt) para a administração de testosterona
DK1044064T3 (da) Overtrækningsindretning til granula til indtagelse ad oral vej
ATE211383T1 (de) Topische aciclovir-zubereitung
PT96045A (pt) Sistema transcutaneo aperfeicoado para aplicacao de compostos farmacologicamente activos em condicoes de ph controlado
NO985079L (no) Eksplosiv formulering
YU29496A (sh) So pirolidinil metil indola
ES1030618Y (es) Dispositivo perfeccionado para la formacion de estanterias.
ES1033586Y (es) Dispositivo para la administracion de medicion en aerosol.
UY24800A1 (es) Sistema solubilizante/estabilizante anhidro, emulsionable o microemulsionable en agua, para la solubilización de los derivados hidrofobos de n-sulfonil indolina.
ES1006366Y (es) Sistema de disparo en una voz para munecos.
ES1019987Y (es) Blanco para tiro perfeccionado.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 697869

Country of ref document: ES